Advocacy Hub | CNSF Members
Updates & Recommendations |
|
from HEALTH CANADA - Proactive Risk Management Projects / Projets de gestion proactive des risques (HC/SC) 02 December 2022 Raising Awareness – Avoiding Unauthorized Health Products Online (presentation materials) Sensibilisation – Éviter les produits de santé non autorisés en ligne (matériel de présentation) The presentation slides can be reviewed by health care professionals at their convenience. Health care professionals are also encouraged to put the handout up at their office or disseminate physical or electronic copies to their clients/patients. The handout speaks to the risks of buying health products online and avoiding unauthorized health products. It also summarizes a list of resources on Health Canada’s webpages. |
|
from the CNSF Advocacy Committee 06 June 2022 The CNSF is contacting you urgently with respect to an immediate and ongoing shortage of intravenous iodinated contrast (radio-contrast media) in Canada. |
|
from the Canadian League Against Epilepsy (CLAE) 16 April 2021 Oxcarbazepine Shortage Communication The Canadian League Against Epilepsy is currently working with Health Canada’s Drug Shortages Unit to determine the impact of Apotex and JAMP’s extended shortage on Oxcarbazepine supply. |
|
from the Canadian Stroke Consortium (CSC) 8 May 2021 What should we do as neurologists? Disseminate this information to your trainees, and neurology colleagues to spread awareness with respect to recognizing this entity and the distinct treatment strategy for this condition. |
